Feb 27, 2015, 00:00
by
Michael Croft
February 27, 2015 | The FDA has proposed a rule
to allow generic drug makers to update product labels on their
medicines when they learn of safety risks, but the pharmaceutical
industry has countered with its own proposal. WSJ